Physician's Weekly Podcast

Eye-to-Eye: An inDepth on Vision Loss and Healthcare Utilizations; And A Novel Intervention for Vision Loss

August 03, 2022 Physician's Weekly
Physician's Weekly Podcast
Eye-to-Eye: An inDepth on Vision Loss and Healthcare Utilizations; And A Novel Intervention for Vision Loss
Show Notes

Welcome to this episode of Physician’s Weekly podcast. I am your host, Dr. Rachel Giles, from Medicom Medical Publishers, in collaboration with Physician’s Weekly. 

Earlier this week I was listening to National Public Radio’s This American Life podcast, which featured blind comedian Darryl Lenox, who talked about how his trust in strangers dramatically shifted after he lost his sight. It got me thinking about how being visually impaired is truly an obstacle to care in some circumstances and brought me to the idea of this inDEPTH episode. 

Today’s episode features two interviews. We start off by exploring the association of vision loss on health care utilization, functional implications of vision loss, ethical and communication issues in patient-centered care delivery, patient engagement, and adherence. In our second interview, we go for a more optimistic ending, in which Physician’s Weekly’s Chris Cole interviews Dr. Andrea Lora Kossler, a plastic and reconstructive surgeon at the Byers Eye Institute Stanford University School of Medicine, in California, about her study published this month Aug 2022, about teprotumumab in retaining functional vision. 

But first I interview Professor Alan R. Morse from the Department of Ophthalmology, Columbia University. 

Enjoy listening!


Additional reading

Morse AR, Seiple W, Talwar N, Lee PP, Stein JD. Association of Vision Loss With Hospital Use and Costs Among Older Adults. JAMA Ophthalmol. 2019 Jun 1;137(6):634-640. 

GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e144-e160.

Ugradar S, Kang J, Kossler AL, Zimmerman E, Braun J, Harrison AR, Bose S, Cockerham K, Douglas RS. Teprotumumab for the treatment of chronic thyroid eye disease. Eye (Lond). 2022 Aug;36(8):1553-1559

Lu TJ, Amarikwa L, Sears CM, Kossler AL. Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy. Curr Neurol Neurosci Rep. 2022 Jun;22(6):313-325.

Let us know what you thought of this week’s episode on Twitter: @physicianswkly

Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at!

Thanks for listening!